Compare · DOOO vs EW
DOOO vs EW
Side-by-side comparison of BRP Inc. (Recreational Products) Common Subordinate Voting Sha (DOOO) and Edwards Lifesciences Corporation (EW): market cap, price performance, sector, and recent activity on the wire.
Summary
- DOOO operates in Consumer Discretionary, while EW operates in Health Care - the two are in different parts of the market.
- EW is the larger of the two at $47.58B, about 7.2x DOOO ($6.63B).
- Over the past year, DOOO is up 53.8% and EW is up 3.4% - DOOO leads by 50.4 points.
- EW has hit the wire 9 times in the past 4 weeks while DOOO has been quiet.
- Both have 25 recent analyst ratings on file.
- Company
- BRP Inc. (Recreational Products) Common Subordinate Voting Sha
- Edwards Lifesciences Corporation
- Price
- $76.81+2.26%
- $82.65-1.31%
- Market cap
- $6.63B
- $47.58B
- 1M return
- +21.30%
- -7.80%
- 1Y return
- +53.80%
- +3.35%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 9
- Recent ratings
- 25
- 25
BRP Inc. (Recreational Products) Common Subordinate Voting Sha
BRP Inc., together with its subsidiaries, designs, develops, manufactures, distributes, and markets powersports vehicles and marine products worldwide. It operates in two segments, Powersports and Marine. The company offers all-terrain, side-by-side, and three-wheeled vehicles; seasonal products, such as snowmobiles and personal watercraft; and engines for jet boats, outboards, karts, motorcycles, and recreational aircraft. It also provides parts, accessories, and apparel, as well as other services. The company sells its products through a network of independent dealers and distributors, as well as to original equipment manufacturers. The company was formerly known as J.A. Bombardier (J.A.B.) Inc. and changed its name to BRP Inc. in April 2013. BRP Inc. was founded in 1937 and is headquartered in Valcourt, Canada.
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Latest DOOO
- SEC Form 6-K filed by BRP Inc. (Recreational Products) Common Subordinate Voting Sha
- SEC Form 6-K filed by BRP Inc. (Recreational Products) Common Subordinate Voting Sha
- SEC Form 6-K filed by BRP Inc. (Recreational Products) Common Subordinate Voting Sha
- BRP ANNOUNCES THE RENEWAL OF ITS NORMAL COURSE ISSUER BID
- BRP PRESENTS ITS THIRD QUARTER RESULTS FOR FISCAL YEAR 2026
- Can-Am to Return to Dakar Rally with Proven Champions, New Hopefuls, and Race-Tested Maverick R Platform
- Can-Am Unveils the Industry's Most Affordable HVAC-Equipped Side-by-Sides and a New Camouflage Outlander Electric
- BRP Will Present its Third Quarter Fiscal Year 2026 Results
- Amendment: SEC Form SCHEDULE 13G/A filed by BRP Inc. (Recreational Products) Common Subordinate Voting Sha
- Amendment: SEC Form SCHEDULE 13G/A filed by BRP Inc. (Recreational Products) Common Subordinate Voting Sha
Latest EW
- Edwards Lifesciences upgraded by Leerink Partners with a new price target
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports Second Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
- CVP, EMEACLA Bruls Annette covered exercise/tax liability with 109 shares, decreasing direct ownership by 0.53% to 20,628 units (SEC Form 4) (for withholding tax)
- CVP, Chief Financial Officer Mistras Theodora was granted 99,920 shares (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,762 worth of shares (619 units at $91.70) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 377 shares, decreasing direct ownership by 0.93% to 40,034 units (SEC Form 4) to cover taxes
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,577 worth of shares (619 units at $91.40) as part of a pre-agreed trading plan (SEC Form 4)
- Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves